Clinical Trial

A Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuation

Study acronym: QFR-REAL
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This prospective, multicenter observational registry aims to establish a QFR-based quality control standard system for coronary revascularization in patients with coronary artery disease. The study will enroll over 10,000 patients with visually estimated at least one main branch coronary stenosis ≥50% from more than 50 centers across China (covering provincial, municipal, and county-level hospitals). Coronary angiographic images and intracoronary imaging (if available) will be collected and retrospectively analyzed by an independent core laboratory. The primary endpoint is QFR acquisition accessibility, defined as the mean of QFR usage proportion across centers.
Trial Details
NCT Number NCT07766434
Lead Sponsor China National Center for Cardiovascular Diseases
Collaborators: Guangdong Provincial People's Hospital, First Affiliated Hospital Xi'an Jiaotong University, Sir Run Run Shaw Hospital, Fuwai Huazhong Cardiovascular Hospital, Fuwai Yunnan Cardiovascular Hospital, Second Hospital of Jilin University
Conditions Coronary Artery Disease
Enrollment 10,000 participants
Start Date 2026-08
Primary Completion 2028-07 (estimated)
Study Completion 2029-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-14